Tekla Life Sciences Investors HQL:NYSE

RT Quote | NYSE | USD
Last | 4:10 PM EST
21.81quote price arrow up+0.43 (+2.01%)
Volume
73,288
52 week range
11.44 - 22.32

...

Loading . . .

KEY STATS

  • Open21.53
  • Day High21.90
  • Day Low21.53
  • Prev Close21.38
  • 52 Week High22.32
  • 52 Week High Date02/19/21
  • 52 Week Low11.44
  • 52 Week Low Date03/18/20
  • Market Cap512.32M
  • Shares Out23.49M
  • 10 Day Average Volume0.08M
  • Dividend1.72
  • Dividend Yield7.89%
  • Beta0.98
  • 1 Year % Change24.84

RATIOS/PROFITABILITY

  • EPS (TTM)5.11
  • P/E (TTM)4.27
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-2.115M
  • ROE (MRQ)28.38%
  • Revenue (MRQ)3.39M
  • Gross Margin (MRQ)-40.93%
  • Net Margin (MRQ)3,628.14%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date02/25/2021
  • Div Amount0.43
  • Split Date-
  • Split Factor-

Latest Tekla Life Sciences Investors News

There is no recent news for this security.

Latest HQL News From Our Partners

February 21, 2021

February 19, 2021

QUOTE FINDER

Profile

MORE
Tekla Life Sciences Investors (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in the United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, agriculture, and environmental management....
Daniel Omstead Ph.D.
President
Address
100 FEDERAL STREET, 19TH FLOOR
Boston, MA
02109-4884
United States